Bill Text: MN HF3664 | 2023-2024 | 93rd Legislature | Introduced
Bill Title: Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: (Introduced - Dead) 2024-03-18 - Author added Hemmingsen-Jaeger [HF3664 Detail]
Download: Minnesota-2023-HF3664-Introduced.pdf